Vaccination Against COVID-19 in Chronic Kidney Disease

Launched by HEINRICH-HEINE UNIVERSITY, DUESSELDORF · Feb 4, 2021

Keywords

ClinConnect Summary

This clinical trial is studying how well the COVID-19 vaccine works in people with severe kidney disease, specifically those who are on dialysis or have had a kidney transplant. The goal is to understand the vaccine's effectiveness in patients who may not respond as well to vaccines due to their health conditions.

If you or a loved one is 18 years or older, receiving dialysis (either hemodialysis or peritoneal dialysis), and able to give consent, you may be eligible to participate. The study is currently recruiting participants and aims to gather important information about the vaccine response in this group. Those who join the trial can expect to receive the COVID-19 vaccine and be monitored for how their bodies respond to it. This research is crucial for ensuring that individuals with chronic kidney disease receive the best possible protection against COVID-19.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • receiving dialysis (hemodialysis or peritoneal dialysis)
• • capable of giving consent
• • age 18 or older
• Exclusion Criteria:
• • - non-capable of giving consent